Dec 14, 2023
1:5
For every 5 shares held, investors received 1. The price per share adjusted from $0.62 to $0.12.
The split itself did not change the total investment value.
Genetic Technologies Limited (GENE) trades on the NASDAQ Capital Market in the Medical - Diagnostics & Research industry.
Genetic Technologies Limited company overviewThe latest split shown was on December 14, 2023. It was a 1-for-5 reverse split, so shareholders received 1 share for every 5 they held.
This history records 4 reverse splits between January 20, 2015 and December 14, 2023.
Already premium? Sign in